
Reset all filters
01 3AbbVie Corporation
Reset all filters
01 32781891
Reset all filters
01 3UPADACITINIB
Reset all filters
01 3TABLET (EXTENDED-RELEASE)
Reset all filters
01 32030-12-01
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Brand Name : RINVOQ
Patent Number : 2781891
Filing Date : 2010-12-01
Strength per Unit : 15 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Brand Name : RINVOQ
Patent Number : 2781891
Filing Date : 2010-12-01
Strength per Unit : 30mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Brand Name : RINVOQ
Patent Number : 2781891
Filing Date : 2010-12-01
Strength per Unit : 45mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-01
Date Granted : 2018-02-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF